Judith S Brand1, Edoardo Colzani2, Anna L V Johansson2, Johan Giesecke2, Mark Clements2, Jonas Bergh3, Per Hall2, Kamila Czene2. 1. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Electronic address: judith.brand@ki.se. 2. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. 3. Department of Oncology-Pathology, Radiumhemmet, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
Abstract
OBJECTIVES: Infections are a common cause of hospitalization in breast cancer patients. We studied the risk, clinical characteristics and outcomes of infection-related hospitalizations in this patient population. METHODS: A Swedish registry-based study including 8338 breast cancer patients diagnosed between 2001 and 2008, followed prospectively for infection-related hospitalizations until 2010. Standardized incidence ratios (SIRs) were calculated using background rates from the general female population. Associations with clinical characteristics and mortality were analyzed using flexible parametric survival models. RESULTS: In total, 720 patients experienced an infection-related hospitalization during a median follow-up of 4.9 years. Infection rates were highest within the first year of diagnosis (SIR = 5.61, 95% CI; 4.98-6.32), and site-specific risks were most pronounced for sepsis (SIR = 3.14, 95% CI; 2.66-3.71) and skin infections (SIR = 2.80, 95% CI; 2.24-3.50). Older age at diagnosis, comorbidities, markers of tumor aggressiveness, chemotherapy and axillary node dissection were independent predictors of infectious disease risk. Infection-related hospitalizations were also independently associated with overall and breast cancer-specific death. CONCLUSIONS: A significant number of breast cancer patients are hospitalized with an infection following diagnosis, which in turn predicts poor prognosis. The risk profile of infection-related hospitalizations is multifactorial, including patient, tumor and treatment-related factors.
OBJECTIVES: Infections are a common cause of hospitalization in breast cancerpatients. We studied the risk, clinical characteristics and outcomes of infection-related hospitalizations in this patient population. METHODS: A Swedish registry-based study including 8338 breast cancerpatients diagnosed between 2001 and 2008, followed prospectively for infection-related hospitalizations until 2010. Standardized incidence ratios (SIRs) were calculated using background rates from the general female population. Associations with clinical characteristics and mortality were analyzed using flexible parametric survival models. RESULTS: In total, 720 patients experienced an infection-related hospitalization during a median follow-up of 4.9 years. Infection rates were highest within the first year of diagnosis (SIR = 5.61, 95% CI; 4.98-6.32), and site-specific risks were most pronounced for sepsis (SIR = 3.14, 95% CI; 2.66-3.71) and skin infections (SIR = 2.80, 95% CI; 2.24-3.50). Older age at diagnosis, comorbidities, markers of tumor aggressiveness, chemotherapy and axillary node dissection were independent predictors of infectious disease risk. Infection-related hospitalizations were also independently associated with overall and breast cancer-specific death. CONCLUSIONS: A significant number of breast cancerpatients are hospitalized with an infection following diagnosis, which in turn predicts poor prognosis. The risk profile of infection-related hospitalizations is multifactorial, including patient, tumor and treatment-related factors.
Authors: Ai-Min Jiang; Na Liu; Rim Ali Said; Meng-Di Ren; Huan Gao; Xiao-Qiang Zheng; Xiao Fu; Xuan Liang; Zhi-Ping Ruan; Yu Yao; Tao Tian Journal: Cancer Manag Res Date: 2020-06-25 Impact factor: 3.989
Authors: Haomin Yang; Yudi Pawitan; Wei He; Louise Eriksson; Natalie Holowko; Per Hall; Kamila Czene Journal: Breast Cancer Res Date: 2019-08-16 Impact factor: 6.466
Authors: Thomas Johannesson Hjelholt; Thomas Bøjer Rasmussen; Anouchka Seesaghur; Rohini K Hernandez; Andrea Marongiu; Niels Obel; Henrik T Toft Sørensen; A B Pedersen Journal: BMJ Open Date: 2021-12-01 Impact factor: 2.692